Sulfur amino acid metabolism (Homo sapiens)

From WikiPathways

Jump to: navigation, search
125, 3729, 46, 49272314, 219, 16, 44, 456, 10, 31, 3643287, 393, 127, 392518, 46, 4922, 48207, 3919, 34261338357, 3987, 39242, 33, 411540, 472632304, 59, 16, 44, 454417mitochondrial matrixcytosolmitochondrial intermembrane spacesulfanegenCysS248-MPSTL-Cystathionine2OBUTAMTRR 2xHC-SQRDL(1-450)MRI1FAD AHCY:NAD+ tetramerFe2+ MALHCNMeCbl SQRDL(1-450)sulfite(2-)L-CysNADH3-SulfinoalanineAdeH2SH+Zn2+ HTAUDH3MPYRAde-RibL-Ser2,3-DMPPMTRR:MTR(MeCbl)H2OH2OMoCo (dioxyo) PXLP AHCY Zn2+ S2O3(2-)ETHE1:2Zn2+GSHPXLP-CBS DMGLYPiTSTMAT1A multimersCTH TAUL-GluO2PiNAD+ H+FAD SO3(2-)heme MTRR H+SO4(2-)FMN H2OHSO3-BETCysS248-MPST:TXN2CSAD HTAU2-OxoacidCTH SLC25A10ARD:Fe++SUOX SQR:FADTSTD1H+HCYSGADL1 2OGPXLP-GOT2 GOT1 CTH tetramer:PXLPFAD NH3CTH tetramer:PXLPPXLP L-LanthionineCO2Fe2+ H2OPXLP K+ L-CysMg2+ O22xHC-SQRDL(1-450) APIP:Zn++H2O2BHMT2:Zn2+ tetramerMTRR:MTR(cob(I)alamin)Mg2+ TXN2GADL1:PXLP4MTOBUTAH2SHCOOHZn2+ MTAP PYRH2OH2OETHE1 MALMTRIBUPAPIP ADO ADO:Fe2+Zn2+ TXN2 H2OCSAD dimerH+O2PXLP H+2AETO2O2BHMT H2OPXLP HC-TXN2Zn2+ CSAE1:Mg++ADI1 Fe2+ PiAcireductoneMTR AdoMetBHMT2 CysS-SQRDL(1-450)CysS248-MPST SO4(2-)L-amino acidCoQMAT1A L-MetBHMT:Zn2+ tetramerFMN AdoHcyCDO1 ATPHSCNMTRIBPH2OMTAP trimerMPSTcob(I)alamin MTADGOT1 dimerHLANCBS tetramerholo-SUOXQH2H+PPiH2OGSSGH2SGOT2 dimerSMMENOPH1 Zn2+ NAD+MTR CDO1:Fe2+429419119


Description

The main sulfur amino acids are methionine, cysteine, homocysteine and taurine. Of these, the first two are proteinogenic.

This group of reactions contains all processes that 1) break down sulfur amino acids, 2) interconvert between them, and 3) synthesize them from solved sulfide which comes from sulfate assimilation and reduction. Only plants and microorganisms employ all processes. Humans cannot de novo synthesize any sulfur amino acid, nor convert cysteine to methionine (Brosnan & Brosnan, 2006). View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 1614635
Reactome-version 
Reactome version: 65
Reactome Author 
Reactome Author: Stephan, Ralf

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Brosnan JT, Brosnan ME.; ''The sulfur-containing amino acids: an overview.''; PubMed Europe PMC Scholia
  2. Camacho-Vanegas O, Camacho SC, Till J, Miranda-Lorenzo I, Terzo E, Ramirez MC, Schramm V, Cordovano G, Watts G, Mehta S, Kimonis V, Hoch B, Philibert KD, Raabe CA, Bishop DF, Glucksman MJ, Martignetti JA.; ''Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts.''; PubMed Europe PMC Scholia
  3. Feng C, Tollin G, Enemark JH.; ''Sulfite oxidizing enzymes.''; PubMed Europe PMC Scholia
  4. Chauncey TR, Westley J.; ''The catalytic mechanism of yeast thiosulfate reductase.''; PubMed Europe PMC Scholia
  5. Melideo SL, Jackson MR, Jorns MS.; ''Biosynthesis of a central intermediate in hydrogen sulfide metabolism by a novel human sulfurtransferase and its yeast ortholog.''; PubMed Europe PMC Scholia
  6. Kimura Y, Mikami Y, Osumi K, Tsugane M, Oka J, Kimura H.; ''Polysulfides are possible H2S-derived signaling molecules in rat brain.''; PubMed Europe PMC Scholia
  7. Steegborn C, Clausen T, Sondermann P, Jacob U, Worbs M, Marinkovic S, Huber R, Wahl MC.; ''Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration.''; PubMed Europe PMC Scholia
  8. Ye S, Wu X, Wei L, Tang D, Sun P, Bartlam M, Rao Z.; ''An insight into the mechanism of human cysteine dioxygenase. Key roles of the thioether-bonded tyrosine-cysteine cofactor.''; PubMed Europe PMC Scholia
  9. Smeets A, Evrard C, Landtmeters M, Marchand C, Knoops B, Declercq JP.; ''Crystal structures of oxidized and reduced forms of human mitochondrial thioredoxin 2.''; PubMed Europe PMC Scholia
  10. Kimura Y, Toyofuku Y, Koike S, Shibuya N, Nagahara N, Lefer D, Ogasawara Y, Kimura H.; ''Identification of H2S3 and H2S produced by 3-mercaptopyruvate sulfurtransferase in the brain.''; PubMed Europe PMC Scholia
  11. Doyle JM, Schininà ME, Bossa F, Doonan S.; ''The amino acid sequence of cytosolic aspartate aminotransferase from human liver.''; PubMed Europe PMC Scholia
  12. Wilson HL, Wilkinson SR, Rajagopalan KV.; ''The G473D mutation impairs dimerization and catalysis in human sulfite oxidase.''; PubMed Europe PMC Scholia
  13. Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C, Levitt MD, Prelle A, Fagiolari G, Rimoldi M, Zeviani M.; ''Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.''; PubMed Europe PMC Scholia
  14. Turner MA, Yuan CS, Borchardt RT, Hershfield MS, Smith GD, Howell PL.; ''Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength.''; PubMed Europe PMC Scholia
  15. Szegedi SS, Castro CC, Koutmos M, Garrow TA.; ''Betaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferase.''; PubMed Europe PMC Scholia
  16. Holzerova E, Danhauser K, Haack TB, Kremer LS, Melcher M, Ingold I, Kobayashi S, Terrile C, Wolf P, Schaper J, Mayatepek E, Baertling F, Friedmann Angeli JP, Conrad M, Strom TM, Meitinger T, Prokisch H, Distelmaier F.; ''Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration.''; PubMed Europe PMC Scholia
  17. Berger LC, Wilson J, Wood P, Berger BJ.; ''Methionine regeneration and aspartate aminotransferase in parasitic protozoa.''; PubMed Europe PMC Scholia
  18. Aita N, Ishii K, Akamatsu Y, Ogasawara Y, Tanabe S.; ''Cloning and expression of human liver rhodanese cDNA.''; PubMed Europe PMC Scholia
  19. Mato JM, Alvarez L, Ortiz P, Pajares MA.; ''S-adenosylmethionine synthesis: molecular mechanisms and clinical implications.''; PubMed Europe PMC Scholia
  20. Wang H, Pang H, Bartlam M, Rao Z.; ''Crystal structure of human E1 enzyme and its complex with a substrate analog reveals the mechanism of its phosphatase/enolase activity.''; PubMed Europe PMC Scholia
  21. Yang X, Hu Y, Yin DH, Turner MA, Wang M, Borchardt RT, Howell PL, Kuczera K, Schowen RL.; ''Catalytic strategy of S-adenosyl-L-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions.''; PubMed Europe PMC Scholia
  22. Liu P, Ge X, Ding H, Jiang H, Christensen BM, Li J.; ''Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis.''; PubMed Europe PMC Scholia
  23. Li F, Feng Q, Lee C, Wang S, Pelleymounter LL, Moon I, Eckloff BW, Wieben ED, Schaid DJ, Yee V, Weinshilboum RM.; ''Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization.''; PubMed Europe PMC Scholia
  24. Oram SW, Ai J, Pagani GM, Hitchens MR, Stern JA, Eggener S, Pins M, Xiao W, Cai X, Haleem R, Jiang F, Pochapsky TC, Hedstrom L, Wang Z.; ''Expression and function of the human androgen-responsive gene ADI1 in prostate cancer.''; PubMed Europe PMC Scholia
  25. Hildebrandt TM, Grieshaber MK.; ''Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria.''; PubMed Europe PMC Scholia
  26. Kabuyama Y, Litman ES, Templeton PD, Metzner SI, Witze ES, Argast GM, Langer SJ, Polvinen K, Shellman Y, Chan D, Shabb JB, Fitzpatrick JE, Resing KA, Sousa MC, Ahn NG.; ''A mediator of Rho-dependent invasion moonlights as a methionine salvage enzyme.''; PubMed Europe PMC Scholia
  27. Dominy JE, Simmons CR, Hirschberger LL, Hwang J, Coloso RM, Stipanuk MH.; ''Discovery and characterization of a second mammalian thiol dioxygenase, cysteamine dioxygenase.''; PubMed Europe PMC Scholia
  28. Janosík M, Kery V, Gaustadnes M, Maclean KN, Kraus JP.; ''Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region.''; PubMed Europe PMC Scholia
  29. Moeller BM, Crankshaw DL, Briggs J, Nagasawa HT, Patterson SE.; ''In-vitro mercaptopyruvate sulfurtransferase species comparison in humans and common laboratory animals.''; PubMed Europe PMC Scholia
  30. Nagahara N, Li Q, Sawada N.; ''Do antidotes for acute cyanide poisoning act on mercaptopyruvate sulfurtransferase to facilitate detoxification?''; PubMed Europe PMC Scholia
  31. Koike S, Kawamura K, Kimura Y, Shibuya N, Kimura H, Ogasawara Y.; ''Analysis of endogenous H2S and H2Sn in mouse brain by high-performance liquid chromatography with fluorescence and tandem mass spectrometric detection.''; PubMed Europe PMC Scholia
  32. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA.; ''Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders.''; PubMed Europe PMC Scholia
  33. Kamatani N, Nelson-Rees WA, Carson DA.; ''Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.''; PubMed Europe PMC Scholia
  34. Corrales FJ, Pérez-Mato I, Sánchez Del Pino MM, Ruiz F, Castro C, García-Trevijano ER, Latasa U, Martínez-Chantar ML, Martínez-Cruz A, Avila MA, Mato JM.; ''Regulation of mammalian liver methionine adenosyltransferase.''; PubMed Europe PMC Scholia
  35. Nakamura H, Yatsuki J, Ubuka T.; ''Production of hypotaurine, taurine and sulfate in rats and mice injected with L-cysteinesulfinate.''; PubMed Europe PMC Scholia
  36. Kimura H.; ''Hydrogen polysulfide (H2S n ) signaling along with hydrogen sulfide (H2S) and nitric oxide (NO).''; PubMed Europe PMC Scholia
  37. Theissen U, Hoffmeister M, Grieshaber M, Martin W.; ''Single eubacterial origin of eukaryotic sulfide:quinone oxidoreductase, a mitochondrial enzyme conserved from the early evolution of eukaryotes during anoxic and sulfidic times.''; PubMed Europe PMC Scholia
  38. Guion-Rain M-C, Portemer C, Chatagner F.; ''Rat liver cysteine sulfinate decarboxylase: purification, new appraisal of the molecular weight and determination of catalytic properties.''; PubMed Europe PMC Scholia
  39. Chiku T, Padovani D, Zhu W, Singh S, Vitvitsky V, Banerjee R.; ''H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia.''; PubMed Europe PMC Scholia
  40. Fiermonte G, Dolce V, Arrigoni R, Runswick MJ, Walker JE, Palmieri F.; ''Organization and sequence of the gene for the human mitochondrial dicarboxylate carrier: evolution of the carrier family.''; PubMed Europe PMC Scholia
  41. Della Ragione F, Cartenì-Farina M, Gragnaniello V, Schettino MI, Zappia V.; ''Purification and characterization of 5'-deoxy-5'-methylthioadenosine phosphorylase from human placenta.''; PubMed Europe PMC Scholia
  42. Martini F, Angelaccio S, Barra D, Pascarella S, Maras B, Doonan S, Bossa F.; ''The primary structure of mitochondrial aspartate aminotransferase from human heart.''; PubMed Europe PMC Scholia
  43. Zhou SL, Gordon RE, Bradbury M, Stump D, Kiang CL, Berk PD.; ''Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells.''; PubMed Europe PMC Scholia
  44. Yadav PK, Yamada K, Chiku T, Koutmos M, Banerjee R.; ''Structure and kinetic analysis of H2S production by human mercaptopyruvate sulfurtransferase.''; PubMed Europe PMC Scholia
  45. Kimura H.; ''Signaling molecules: hydrogen sulfide and polysulfide.''; PubMed Europe PMC Scholia
  46. HIMWICH WA, SAUNDERS JP.; ''Enzymatic conversion of cyanide to thiocyanate.''; PubMed Europe PMC Scholia
  47. Crompton M, Palmieri F, Capano M, Quagliariello E.; ''The transport of sulphate and sulphite in rat liver mitochondria.''; PubMed Europe PMC Scholia
  48. Liu P, Torrens-Spence MP, Ding H, Christensen BM, Li J.; ''Mechanism of cysteine-dependent inactivation of aspartate/glutamate/cysteine sulfinic acid α-decarboxylases.''; PubMed Europe PMC Scholia
  49. Zottola MA.; ''A partial exploration of the potential energy surfaces of SCN and HSCN: implications for the enzyme-mediated detoxification of cyanide.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
100972view21:08, 31 October 2018ReactomeTeamreactome version 65
100509view19:42, 31 October 2018ReactomeTeamreactome version 64
100055view16:26, 31 October 2018ReactomeTeamreactome version 63
99607view14:59, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
99219view12:44, 31 October 2018ReactomeTeamreactome version 62
93813view13:38, 16 August 2017ReactomeTeamreactome version 61
93357view11:21, 9 August 2017ReactomeTeamreactome version 61
88427view12:04, 5 August 2016FehrhartOntology Term : 'amino acid metabolic pathway' added !
86439view09:18, 11 July 2016ReactomeTeamreactome version 56
83464view12:29, 18 November 2015ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
2,3-DMPPMetaboliteCHEBI:58828 (ChEBI)
2-OxoacidMetaboliteCHEBI:35179 (ChEBI)
2AETMetaboliteCHEBI:17141 (ChEBI)
2OBUTAMetaboliteCHEBI:30831 (ChEBI)
2OGMetaboliteCHEBI:30915 (ChEBI)
2xHC-SQRDL(1-450) ProteinQ9Y6N5 (Uniprot-TrEMBL)
2xHC-SQRDL(1-450)ProteinQ9Y6N5 (Uniprot-TrEMBL)
3-SulfinoalanineMetaboliteCHEBI:16345 (ChEBI)
3MPYRMetaboliteCHEBI:16208 (ChEBI)
4MTOBUTAMetaboliteCHEBI:16723 (ChEBI)
ADI1 ProteinQ9BV57 (Uniprot-TrEMBL)
ADO ProteinQ96SZ5 (Uniprot-TrEMBL)
ADO:Fe2+ComplexR-HSA-6814156 (Reactome)
AHCY ProteinP23526 (Uniprot-TrEMBL)
AHCY:NAD+ tetramerComplexR-HSA-174358 (Reactome)
APIP ProteinQ96GX9 (Uniprot-TrEMBL)
APIP:Zn++ComplexR-HSA-1237083 (Reactome)
ARD:Fe++ComplexR-HSA-1237173 (Reactome)
ATPMetaboliteCHEBI:15422 (ChEBI)
AcireductoneMetaboliteCHEBI:58795 (ChEBI)
Ade-RibMetaboliteCHEBI:16335 (ChEBI)
AdeMetaboliteCHEBI:16708 (ChEBI)
AdoHcyMetaboliteCHEBI:16680 (ChEBI)
AdoMetMetaboliteCHEBI:15414 (ChEBI)
BETMetaboliteCHEBI:17750 (ChEBI)
BHMT ProteinQ93088 (Uniprot-TrEMBL)
BHMT2 ProteinQ9H2M3 (Uniprot-TrEMBL)
BHMT2:Zn2+ tetramerComplexR-HSA-5696826 (Reactome)
BHMT:Zn2+ tetramerComplexR-HSA-6798211 (Reactome)
CBS tetramerComplexR-HSA-1614610 (Reactome)
CDO1 ProteinQ16878 (Uniprot-TrEMBL)
CDO1:Fe2+ComplexR-HSA-1614609 (Reactome)
CO2MetaboliteCHEBI:16526 (ChEBI)
CSAMetaboliteCHEBI:16345 (ChEBI)
CSAD ProteinQ9Y600 (Uniprot-TrEMBL)
CSAD dimerComplexR-HSA-1655430 (Reactome)
CTH ProteinP32929 (Uniprot-TrEMBL)
CTH tetramer:PXLPComplexR-HSA-1625212 (Reactome)
CoQMetaboliteCHEBI:46245 (ChEBI)
CysS-SQRDL(1-450)ProteinQ9Y6N5 (Uniprot-TrEMBL)
CysS248-MPST ProteinP25325 (Uniprot-TrEMBL)
CysS248-MPST:TXN2ComplexR-HSA-9035480 (Reactome)
CysS248-MPSTProteinP25325 (Uniprot-TrEMBL)
DMGLYMetaboliteCHEBI:17724 (ChEBI)
E1:Mg++ComplexR-HSA-1237166 (Reactome)
ENOPH1 ProteinQ9UHY7 (Uniprot-TrEMBL)
ETHE1 ProteinO95571 (Uniprot-TrEMBL)
ETHE1:2Zn2+ComplexR-HSA-1614521 (Reactome)
FAD MetaboliteCHEBI:16238 (ChEBI)
FMN MetaboliteCHEBI:17621 (ChEBI)
Fe2+ MetaboliteCHEBI:18248 (ChEBI)
GADL1 ProteinQ6ZQY3 (Uniprot-TrEMBL)
GADL1:PXLPComplexR-HSA-6787755 (Reactome)
GOT1 ProteinP17174 (Uniprot-TrEMBL)
GOT1 dimerComplexR-HSA-70579 (Reactome)
GOT2 dimerComplexR-HSA-70594 (Reactome)
GSHMetaboliteCHEBI:16856 (ChEBI)
GSSGMetaboliteCHEBI:17858 (ChEBI)
H+MetaboliteCHEBI:15378 (ChEBI)
H2O2MetaboliteCHEBI:16240 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
H2SMetaboliteCHEBI:16136 (ChEBI)
HC-TXN2ProteinQ99757 (Uniprot-TrEMBL)
HCNMetaboliteCHEBI:18407 (ChEBI)
HCOOHMetaboliteCHEBI:30751 (ChEBI)
HCYSMetaboliteCHEBI:17230 (ChEBI)
HLANMetaboliteCHEBI:62856 (ChEBI)
HSCNMetaboliteCHEBI:29200 (ChEBI)
HSO3-MetaboliteCHEBI:17137 (ChEBI)
HTAUMetaboliteCHEBI:16668 (ChEBI)
HTAUDHR-HSA-1655455 (Reactome)
K+ MetaboliteCHEBI:29103 (ChEBI)
L-CysMetaboliteCHEBI:35235 (ChEBI)
L-CystathionineMetaboliteCHEBI:17482 (ChEBI)
L-GluMetaboliteCHEBI:29985 (ChEBI)
L-LanthionineMetaboliteCHEBI:21347 (ChEBI)
L-MetMetaboliteCHEBI:57844 (ChEBI)
L-SerMetaboliteCHEBI:33384 (ChEBI)
L-amino acidMetaboliteCHEBI:59869 (ChEBI)
MALMetaboliteCHEBI:30797 (ChEBI)
MAT1A ProteinQ00266 (Uniprot-TrEMBL)
MAT1A multimersComplexR-HSA-174383 (Reactome)
MPSTProteinP25325 (Uniprot-TrEMBL)
MRI1ProteinQ9BV20 (Uniprot-TrEMBL)
MTADMetaboliteCHEBI:17509 (ChEBI)
MTAP ProteinQ13126 (Uniprot-TrEMBL)
MTAP trimerComplexR-HSA-1237147 (Reactome)
MTR ProteinQ99707 (Uniprot-TrEMBL)
MTRIBPMetaboliteCHEBI:58533 (ChEBI)
MTRIBUPMetaboliteCHEBI:58548 (ChEBI)
MTRR ProteinQ9UBK8 (Uniprot-TrEMBL)
MTRR:MTR(MeCbl)ComplexR-HSA-3149551 (Reactome)
MTRR:MTR(cob(I)alamin)ComplexR-HSA-3149516 (Reactome)
MeCbl MetaboliteCHEBI:28115 (ChEBI)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
MoCo (dioxyo) MetaboliteCHEBI:25372 (ChEBI)
NAD+ MetaboliteCHEBI:15846 (ChEBI)
NAD+MetaboliteCHEBI:15846 (ChEBI)
NADHMetaboliteCHEBI:16908 (ChEBI)
NH3MetaboliteCHEBI:16134 (ChEBI)
O2MetaboliteCHEBI:15379 (ChEBI)
PPiMetaboliteCHEBI:29888 (ChEBI)
PXLP MetaboliteCHEBI:18405 (ChEBI)
PXLP-CBS ProteinP35520 (Uniprot-TrEMBL)
PXLP-GOT2 ProteinP00505 (Uniprot-TrEMBL)
PYRMetaboliteCHEBI:32816 (ChEBI)
PiMetaboliteCHEBI:18367 (ChEBI)
QH2MetaboliteCHEBI:17976 (ChEBI)
S2O3(2-)MetaboliteCHEBI:16094 (ChEBI)
SLC25A10ProteinQ9UBX3 (Uniprot-TrEMBL)
SMMMetaboliteCHEBI:17728 (ChEBI)
SO3(2-)MetaboliteCHEBI:17359 (ChEBI)
SO4(2-)MetaboliteCHEBI:16189 (ChEBI)
SQR:FADComplexR-HSA-1614651 (Reactome)
SQRDL(1-450)ProteinQ9Y6N5 (Uniprot-TrEMBL)
SUOX ProteinP51687 (Uniprot-TrEMBL)
TAUMetaboliteCHEBI:15891 (ChEBI)
TSTD1ProteinQ8NFU3 (Uniprot-TrEMBL)
TSTProteinQ16762 (Uniprot-TrEMBL)
TXN2 ProteinQ99757 (Uniprot-TrEMBL)
TXN2ProteinQ99757 (Uniprot-TrEMBL)
Zn2+ MetaboliteCHEBI:29105 (ChEBI)
cob(I)alamin MetaboliteCHEBI:15982 (ChEBI)
heme MetaboliteCHEBI:17627 (ChEBI)
holo-SUOXComplexR-HSA-1614636 (Reactome)
sulfanegenMetaboliteCHEBI:138170 (ChEBI)
sulfite(2-)MetaboliteCHEBI:17359 (ChEBI)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
2,3-DMPPArrowR-HSA-1237140 (Reactome)
2,3-DMPPR-HSA-1237129 (Reactome)
2-OxoacidArrowR-HSA-1237102 (Reactome)
2AETR-HSA-6814153 (Reactome)
2OBUTAArrowR-HSA-1614583 (Reactome)
2OBUTAArrowR-HSA-1614631 (Reactome)
2OGR-HSA-9012597 (Reactome)
2xHC-SQRDL(1-450)R-HSA-1614665 (Reactome)
3-SulfinoalanineArrowR-HSA-1614645 (Reactome)
3-SulfinoalanineR-HSA-1655443 (Reactome)
3MPYRArrowR-HSA-9012597 (Reactome)
3MPYRR-HSA-9012721 (Reactome)
3MPYRR-HSA-9013471 (Reactome)
3MPYRR-HSA-9034756 (Reactome)
4MTOBUTAArrowR-HSA-1237119 (Reactome)
4MTOBUTAR-HSA-1237102 (Reactome)
ADO:Fe2+mim-catalysisR-HSA-6814153 (Reactome)
AHCY:NAD+ tetramermim-catalysisR-HSA-174401 (Reactome)
APIP:Zn++mim-catalysisR-HSA-1237140 (Reactome)
ARD:Fe++mim-catalysisR-HSA-1237119 (Reactome)
ATPR-HSA-174391 (Reactome)
AcireductoneArrowR-HSA-1237129 (Reactome)
AcireductoneR-HSA-1237119 (Reactome)
Ade-RibArrowR-HSA-174401 (Reactome)
AdeArrowR-HSA-1237160 (Reactome)
AdoHcyR-HSA-174401 (Reactome)
AdoMetArrowR-HSA-174391 (Reactome)
BETR-HSA-1614654 (Reactome)
BHMT2:Zn2+ tetramermim-catalysisR-HSA-5696838 (Reactome)
BHMT:Zn2+ tetramermim-catalysisR-HSA-1614654 (Reactome)
CBS tetramermim-catalysisR-HSA-1614524 (Reactome)
CDO1:Fe2+mim-catalysisR-HSA-1614645 (Reactome)
CO2ArrowR-HSA-1655443 (Reactome)
CO2ArrowR-HSA-6814165 (Reactome)
CSAD dimermim-catalysisR-HSA-1655443 (Reactome)
CSAR-HSA-6814165 (Reactome)
CTH tetramer:PXLPmim-catalysisR-HSA-1614567 (Reactome)
CTH tetramer:PXLPmim-catalysisR-HSA-1614583 (Reactome)
CTH tetramer:PXLPmim-catalysisR-HSA-1614591 (Reactome)
CTH tetramer:PXLPmim-catalysisR-HSA-1614614 (Reactome)
CTH tetramer:PXLPmim-catalysisR-HSA-1614631 (Reactome)
CoQR-HSA-1614665 (Reactome)
CysS-SQRDL(1-450)ArrowR-HSA-1614665 (Reactome)
CysS-SQRDL(1-450)R-HSA-1614605 (Reactome)
CysS-SQRDL(1-450)R-HSA-1614618 (Reactome)
CysS248-MPST:TXN2ArrowR-HSA-9035227 (Reactome)
CysS248-MPST:TXN2R-HSA-9035484 (Reactome)
CysS248-MPSTArrowR-HSA-9034756 (Reactome)
CysS248-MPSTR-HSA-9035227 (Reactome)
DMGLYArrowR-HSA-1614654 (Reactome)
E1:Mg++mim-catalysisR-HSA-1237129 (Reactome)
ETHE1:2Zn2+mim-catalysisR-HSA-1614605 (Reactome)
GADL1:PXLPmim-catalysisR-HSA-6814165 (Reactome)
GOT1 dimermim-catalysisR-HSA-1237102 (Reactome)
GOT2 dimermim-catalysisR-HSA-9012597 (Reactome)
GSHR-HSA-1655879 (Reactome)
GSSGArrowR-HSA-1655879 (Reactome)
H+ArrowR-HSA-1237129 (Reactome)
H+ArrowR-HSA-1614605 (Reactome)
H+ArrowR-HSA-1655453 (Reactome)
H+ArrowR-HSA-5696838 (Reactome)
H+ArrowR-HSA-6814153 (Reactome)
H+R-HSA-1614665 (Reactome)
H+R-HSA-1655879 (Reactome)
H2O2ArrowR-HSA-1614544 (Reactome)
H2OArrowR-HSA-1237140 (Reactome)
H2OArrowR-HSA-1614524 (Reactome)
H2OR-HSA-1237129 (Reactome)
H2OR-HSA-1614544 (Reactome)
H2OR-HSA-1614583 (Reactome)
H2OR-HSA-1614605 (Reactome)
H2OR-HSA-1614614 (Reactome)
H2OR-HSA-1614631 (Reactome)
H2OR-HSA-1655453 (Reactome)
H2OR-HSA-174391 (Reactome)
H2OR-HSA-174401 (Reactome)
H2SArrowR-HSA-1614567 (Reactome)
H2SArrowR-HSA-1614591 (Reactome)
H2SArrowR-HSA-1614614 (Reactome)
H2SArrowR-HSA-1614631 (Reactome)
H2SArrowR-HSA-1655879 (Reactome)
H2SArrowR-HSA-9035484 (Reactome)
H2SR-HSA-1614665 (Reactome)
HC-TXN2ArrowR-HSA-9035484 (Reactome)
HCNR-HSA-9013198 (Reactome)
HCNR-HSA-9013471 (Reactome)
HCNR-HSA-9013533 (Reactome)
HCOOHArrowR-HSA-1237119 (Reactome)
HCYSArrowR-HSA-1614567 (Reactome)
HCYSArrowR-HSA-174401 (Reactome)
HCYSR-HSA-1614524 (Reactome)
HCYSR-HSA-1614567 (Reactome)
HCYSR-HSA-1614631 (Reactome)
HCYSR-HSA-1614654 (Reactome)
HCYSR-HSA-174374 (Reactome)
HCYSR-HSA-5696838 (Reactome)
HLANArrowR-HSA-1614567 (Reactome)
HSCNArrowR-HSA-9013198 (Reactome)
HSCNArrowR-HSA-9013471 (Reactome)
HSCNArrowR-HSA-9013533 (Reactome)
HSO3-R-HSA-9012721 (Reactome)
HTAUArrowR-HSA-1655443 (Reactome)
HTAUArrowR-HSA-6814153 (Reactome)
HTAUArrowR-HSA-6814165 (Reactome)
HTAUDHmim-catalysisR-HSA-1655453 (Reactome)
HTAUR-HSA-1655453 (Reactome)
L-CysArrowR-HSA-1614583 (Reactome)
L-CysArrowR-HSA-1614591 (Reactome)
L-CysR-HSA-1614591 (Reactome)
L-CysR-HSA-1614614 (Reactome)
L-CysR-HSA-1614645 (Reactome)
L-CysR-HSA-9012597 (Reactome)
L-CystathionineArrowR-HSA-1614524 (Reactome)
L-CystathionineR-HSA-1614583 (Reactome)
L-GluArrowR-HSA-9012597 (Reactome)
L-LanthionineArrowR-HSA-1614591 (Reactome)
L-MetArrowR-HSA-1237102 (Reactome)
L-MetArrowR-HSA-1614654 (Reactome)
L-MetArrowR-HSA-174374 (Reactome)
L-MetArrowR-HSA-5696838 (Reactome)
L-MetR-HSA-174391 (Reactome)
L-SerArrowR-HSA-1614614 (Reactome)
L-SerR-HSA-1614524 (Reactome)
L-amino acidR-HSA-1237102 (Reactome)
MALArrowR-HSA-1614546 (Reactome)
MALR-HSA-1614546 (Reactome)
MAT1A multimersmim-catalysisR-HSA-174391 (Reactome)
MPSTArrowR-HSA-9035484 (Reactome)
MPSTR-HSA-9034756 (Reactome)
MPSTmim-catalysisR-HSA-9012721 (Reactome)
MPSTmim-catalysisR-HSA-9013471 (Reactome)
MPSTmim-catalysisR-HSA-9013533 (Reactome)
MPSTmim-catalysisR-HSA-9034756 (Reactome)
MRI1mim-catalysisR-HSA-1237096 (Reactome)
MRI1mim-catalysisR-HSA-1299507 (Reactome)
MTADR-HSA-1237160 (Reactome)
MTAP trimermim-catalysisR-HSA-1237160 (Reactome)
MTRIBPArrowR-HSA-1237160 (Reactome)
MTRIBPArrowR-HSA-1299507 (Reactome)
MTRIBPR-HSA-1237096 (Reactome)
MTRIBUPArrowR-HSA-1237096 (Reactome)
MTRIBUPR-HSA-1237140 (Reactome)
MTRIBUPR-HSA-1299507 (Reactome)
MTRR:MTR(MeCbl)R-HSA-174374 (Reactome)
MTRR:MTR(MeCbl)mim-catalysisR-HSA-174374 (Reactome)
MTRR:MTR(cob(I)alamin)ArrowR-HSA-174374 (Reactome)
NAD+R-HSA-1655453 (Reactome)
NADHArrowR-HSA-1655453 (Reactome)
NH3ArrowR-HSA-1614583 (Reactome)
NH3ArrowR-HSA-1614631 (Reactome)
O2R-HSA-1237119 (Reactome)
O2R-HSA-1614544 (Reactome)
O2R-HSA-1614605 (Reactome)
O2R-HSA-1614645 (Reactome)
O2R-HSA-6814153 (Reactome)
PPiArrowR-HSA-174391 (Reactome)
PYRArrowR-HSA-9012721 (Reactome)
PYRArrowR-HSA-9013471 (Reactome)
PYRArrowR-HSA-9013533 (Reactome)
PYRArrowR-HSA-9034756 (Reactome)
PiArrowR-HSA-1237129 (Reactome)
PiArrowR-HSA-174391 (Reactome)
PiR-HSA-1237160 (Reactome)
QH2ArrowR-HSA-1614665 (Reactome)
R-HSA-1237096 (Reactome) Equilibrium between 5'-methylthio ribose-1-phosphate and 5'-methylthio ribulose-1-phosphate is catalyzed by 5'-methylthio ribose-1-phosphate isomerase. (Kabuyama et al, 2009)
R-HSA-1237102 (Reactome) In the last step MOB gets transaminated to methionine. The reaction was confirmed in yeast, where several transaminases catalyze it, which appears to be also the case in rat. At the moment, the human enzymes involved are unknown but due to homology to the respective enzyme in the parasite Crithidia fasciculata we feel supported to state that human GOT is probably one of the involved transaminases. (Berger et al, 2001)
R-HSA-1237119 (Reactome) Acireducone (1,2-Dihydroxy-3-oxo-5'-methylthiopentene) is oxidized using acireductone dioxygenase and dioxygen. There are two reactions possible, dependent on the metal cofactor: the alternative product 3-methylthiopropionate using nickel was confirmed in Klebsiella. In eukaryotes using iron(II) the result is 4-methylthio-2-oxobutanoate (MOB). (Ju et al, 2006)
R-HSA-1237129 (Reactome) Acireductone synthase (also: enolase-phosphatase E1) catalyzes the dephosphorylation and conversion to enolate of 2,3-dioxo-5'-methylthiopentane-1-phosphate, yielding acireductone. (Wang et al, 2005)
R-HSA-1237140 (Reactome) The human enzyme with 5'-methylthio ribulose-1-phosphate isomerase activity is probably produced from the APIP gene, according to its orthology with the yeast Mde1p enzyme.
R-HSA-1237160 (Reactome) MTA phosphorylase catalyzes the cleavage of adenine from S-methylthioadenosine (MTA) and subsequent phosphorylation of the product, yielding 5'-methylthio ribose-1-phosphate (Kamatani et al. 1981). The active form of the enzyme is a homotrimer (Della Ragione et al. 1985). Mutations in the gene are associated with a rare bone dysplasia and cancer syndrome, DMS-MFH (Camacho-Vanegas et al. 2012).
R-HSA-1299507 (Reactome) Equilibrium between 5'-methylthio ribose-1-phosphate and 5'-methylthio ribulose-1-phosphate is catalyzed by 5'-methylthio ribose-1-phosphate isomerase. (Kabuyama et al, 2009)
R-HSA-1614524 (Reactome) The first step of homocysteine conversion to cysteine is catalyzed by cystathionine beta-lyase, which adds a serine molecule to the substrate. The enzyme is a tetramer with two heme molecules as cofactor (Janosik et al. 2001).
R-HSA-1614544 (Reactome) Sulfite oxidase oxidizes sulfite to sulfate which is among the most important macronutrients in cells and the fourth most abundant anion in human plasma (300 micromolar). The enzyme has a molybdenum-molybdopterin cofactor (MoCo) bound (Wilson et al. 2006, Feng et al. 2007).
R-HSA-1614546 (Reactome) Sulfate leaves the mitochondrion with the help of the dicarboxylate carrier, via antiport with malate (Crompton et al. 1974, Fiemont et al. 1999)
R-HSA-1614567 (Reactome) Excess homocysteine will change the enzymatic activity of CBS such that other reactions than transsulfuration take place. In these reactions, oxobutanoate, lanthionine, and homolanthionine are produced by cystathionine gamma-lyase (CTH) (Chiku et al. 2009, Steegborn et al. 1999)
R-HSA-1614583 (Reactome) Cystathionine is cleaved to cysteine, oxobutanoate, and ammonia by the alpha,gamma-elimination activity of cystathionine gamma-lyase (CTH) (Chiku et al. 2009, Steegborn et al. 1999).
R-HSA-1614591 (Reactome) Excess homocysteine will change the enzymatic activity of CBS such that other reactions than transsulfuration take place. In these reactions, oxobutanoate, lanthionine, and homolanthionine are produced by cystathionine gamma-lyase (CTH) (Chiku et al. 2009, Steegborn et al. 1999)
R-HSA-1614605 (Reactome) The sulfur dioxygenase ETHE1 converts persulfides to sulfite. Loss of this activity leads to the rare ethylmalonyl encephalopathy where the body can no longer detoxify H2S (Tiranti et al, 2009).
R-HSA-1614614 (Reactome) alpha,beta-elimination activity of cystathionine-gamma-lyase (CTH) replaces the sulfur in cysteine with oxygen from water, resulting in serine and toxic hydrogen sulfide, which is further oxidized in mitochondria (Chiku et al. 2009, Steegborn et al. 1999).
R-HSA-1614618 (Reactome) The main reaction catalyzed by rhodanase is not the name-giving detoxification of cyanide to thiocyanate, but the transfer of a sulfur atom from SQR-S-SH onto sulfite yielding thiosulfate during sulfide oxidation. The activity of human rhodanase was inferred from the rat orthologue by Hildebrandt & Grieshaber, 2008.
R-HSA-1614631 (Reactome) Excess homocysteine will change the enzymatic activity of CBS such that other reactions than transsulfuration take place. In these reactions, oxobutanoate, lanthionine, and homolanthionine are produced by cystathionine gamma-lyase (CTH) (Chiku et al. 2009, Steegborn et al. 1999)
R-HSA-1614645 (Reactome) Oxidation of the thiol moiety of cysteine yields sulfinoalanine, which itself is processed to hypotaurine by an as of yet uncharacterized enzyme in humans . Whether further oxidation of hypotaurine to taurine needs an enzyme is unknown at present (Ye et al. 2007).
R-HSA-1614654 (Reactome) Remethylation of homocysteine (HCYS) to methionine (L-Met) can also proceed by using betaine (BET) as a methyl donor, which is oxidised to dimethylglycine (DMGLY). This reaction is also part of choline catabolism, thereby providing a link to folate-dependent, one-carbon metabolism (Li et al. 2008).
R-HSA-1614665 (Reactome) When SQR is in the oxidized state, it can bind hydrogen sulfide as persulfide to one of its own cysteine residue, the electrons being transferred to ubiquinone. After that the additional sulfur is dioxygenated by another enzyme (ETHE1). The activity of human SQR was deduced from the orthologue in Arenicola marina (Theissen et al. 2003, Hildebrandt & Grieshaber 2008).
R-HSA-1655443 (Reactome) Cysteine sulfinic acid decarboxylase (CSAD) mediates the decarboxylase of 3-sulfinoalanine to produce hypotuarine. CSAD functions as a homodimer and requires pyridoxal phosphate as a cofactor. Purification, characterisation and activity of CSAD has been determined from rat liver (Guion-Rain et al. 1975).
R-HSA-1655453 (Reactome) The as yet uncharacterised human enzyme hypotaurine dehydrogenase mediates the oxidation of hypotaurine to produce taurine. All studies to date have been performed predominantly in rat (Nakamura et al. 2006).
R-HSA-1655879 (Reactome) Thiosulfate is able to transfer its sulfur atom to glutathione, a reaction investigated in yeast (Chauncey & Westley 1983). Recombinant human thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1 (TSTD1 aka KAT1) (and its yeast equivalent RDL1) catalyse a predicted thiosulfate-dependent conversion of glutathione (GSH) to glutathione disulfide (GSSG) (Melideo et al. 2014).
R-HSA-174374 (Reactome) A methyl group from 5-methyltetrahydrofolate is transferred to homocysteine (HCYS) via a meCbl intermediate, forming methionine (L-Met) (Leclerc et al. 1996).
R-HSA-174391 (Reactome) S-adenosylmethionine (AdoMet, SAM) is an essential metabolite in all cells. AdoMet is a precursor in the synthesis of polyamines. Methionine adenosyltransferases (MAT) catalyse the only known AdoMet biosynthetic reaction from methionine (L-Met) and ATP. In mammalian tissues, three different forms of MAT (MAT I, MAT III and MAT II) have been identified that are the product of two different genes (MAT1A and MAT2A). MAT1A binds 1 K+ and 2 Mg2+ (or Co2+, not shown here) in tetrameric or dimeric form (Corrales et al. 2002, Mato et al. 1997).
R-HSA-174401 (Reactome) Adenosylhomocysteinase (AHCY) is a tetrameric, NAD+-bound, cytosolic protein that regulates all adenosylmethionine-(AdoMet) dependent transmethylations by hydrolysing the feedback inhibitor adenosylhomocysteine (AdoHcy) to homocysteine (HCYS) and adenosine (Ade-Rib) (Turner et al. 1998, Yang et al. 2003).
R-HSA-5696838 (Reactome) L-homocysteine (LHCYS) is derived from L-methionine (L-Met) and can either be remethylated to reform L-Met or take part in cysteine biosynthesis via the trans-sulfuration pathway. LHCYS remethylation can occur by the action of two enzymes; cobalamin-dependent methionine synthase and betaine-homocysteine methyltransferase, using methyltetrahydrofolate and betaine respectively as methyl donors. A third enzyme, S-methylmethionine-homocysteine S-methyltransferase (BHMT2), can use S-methylmethionine (SMM) as the methyl donor to methylate LHCYS and reform L-Met. BHMT2 is a tetrameric, cytosolic enzyme that requires one Zn2+ ion per subunit as cofactor (Szegedi et al. 2008).
R-HSA-6814153 (Reactome) Cysteine metabolism to its sulfoxidation end-products is dependent upon two iron-dependent enzymes that are the only known mammalian thiol dioxygenases. These two thiol dioxygenases are cysteine dioxygenase (CDO) and 2-aminoethanethiol dioxygenase (ADO, cysteamine dioxygenase ). Both of these thiol dioxygenases are essential for hypotaurine and taurine biosynthesis. ADO adds molecular oxygen to the sulfhydryl group of 2-aminoethanethiol (2AET, cysteamine) to form the sulfinic acid hypotaurine (HTAU) (Dominy et al. 2007).
R-HSA-6814165 (Reactome) Acidic amino acid decarboxylase GADL1 (GADL1) can decarboxylate acidic amino acids such as cysteine sulfinic acid (CSA) to form hypotaurine (HTAU) (Liu et al. 2012, 2013).
R-HSA-9012597 (Reactome) Hydrogen sulfide (H2S) produced endogenously has been established as the third gaseous signaling molecule, a smooth muscle relaxant and a neuroprotectant (Kimura 2011a, 2011b). Three human enzyme systems produce H2S in the brain, retina and vascular endothelial cells. 3-mercaptopyruvate sulphurtransferase (MPST, aka 3MST) in conjunction with cysteine (aspartate) aminotransferase (CAT, aka GOT2) is decribed here. The first step is the reversible transamination between L-cysteine (L-Cys) and 2-oxoglutarate (2OG, aka alpha-ketoglutarate) to form 3-methylpyruvate (3MPYR) and glutamate (Glu) catalysed by GOT2. Two forms of human aspartate aminotransferase (GOT) enzymes exist; cytosolic (GOT1) and mitochondrial (GOT2). Both are dimeric proteins requiring pyridoxal phosphate for activity. Human GOT2 (Zhou et al. 1998) possesses the same catalytic activity as its rat counterpart (Ubuka et al. 1978).
R-HSA-9012721 (Reactome) Hydrogen sulfide (H2S) produced endogenously has been established as the third gaseous signaling molecule, a smooth muscle relaxant and a neuroprotectant (Kimura 2011a, 2011b). Three enzyme systems produce H2S in the brain, retina and vascular endothelial cells (Shibuya et al. 2009a, 2009b, Mikami et al. 2011). 3-mercaptopyruvate sulphurtransferase (MPST, aka 3MST) in conjunction with cysteine (aspartate) aminotransferase (CAT, aka GOT2) is decribed here. In the second step, 3-mercaptopyruvate sulfurtransferase (MPST aka 3MST) mediates the transfer of a sulfur atom from 3-methylpryuvate (3MPYR) to hydrogensulfite (HSO3-) to form thiosulfate (S2O3(2-)) and pyruvate (PYR) (Yadav et al. 2013).
R-HSA-9013198 (Reactome) Cyanide is a potent metabolic poison, a major component of which is binding to and inhibition of cytochrome c oxidase (cytochrome a3), resulting in the rapid inhibition of oxidative phosphorylation (Hall & Rumack 1986). As a result, cells can't utilise oxygen, giving rise to central nervous system, cardiovascular and respiratory dysfunction that can result in permanent neurological defects and, in severe cases, death. At body's pH, cyanide exists mainly in the undissociated form hydrogen cyanide (HCN) which can cross cellular and subcellular membranes such as the blood brain barrier and mitochondrial membranes. Cyanide intoxication can occur after smoke inhalation, industrial exposure, ingestion of cyanogenic substances and cyanogenic food sources such as cassava. Antidotes for HCN poisoning cases include HCN binders, sulfur donors that convert HCN to the less toxic thiosulfate and competitors for HCN enzymatic binding sites such as NO (Petrikovics et al. 2015).

Two pathways in mammals are able to detoxify cyanide as thiocyanate via transfer of a sulfur atom: thiosulfate sulfurtransferase (TST aka rhodanese) in mitochondria and 3-mercaptopyruvate sulfurtransferase (MPST aka 3MST) in cytosol and mitochondria. TST can act to detoxify HCN by transsulfuration, that is mediating the transfer of a sulfur atom from thiosulfate (S2O3(2-)) to HCN to form the less toxic thiocyanic acid (HSCN) (Himwich & Saunders 1948, Aita et al. 1997, Zottola 2009). HSCN can be excreted in urine via the kidneys (Hamel 2011).
R-HSA-9013471 (Reactome) Cyanide is a potent metabolic poison which binds to and inhibits cytochrome c oxidase (cytochrome a3), resulting in the rapid inhibition of oxidative phosphorylation (Hall & Rumack 1986). As a result, cells can't utilise oxygen, giving rise to central nervous system, cardiovascular and respiratory dysfunction that can result in permanent neurological defects and, in severe cases, death. At body's pH, cyanide exists mainly in the undissociated form hydrogen cyanide (HCN) which can cross cellular and subcellular membranes such as the blood brain barrier and mitochondrial membranes. Although humans aren't typically exposed to toxic levels of cyanide, cyanide intoxication can occur after smoke inhalation, industrial exposure, ingestion of cyanogenic substances and cyanogenic food sources such as cassava. Antidotes for HCN poisoning cases include HCN binders, sulfur donors that convert HCN to the less toxic thiosulfate and competitors for HCN enzymatic binding sites such as NO (Nagahara et al. 1999, Petrikovics et al. 2015).

Two pathways in mammals are able to detoxify cyanide as thiocyanate via transfer of a sulfur atom: thiosulfate sulfurtransferase (TST aka rhodanese) in mitochondria and 3-mercaptopyruvate sulfurtransferase (MPST aka 3MST) in cytosol and mitochondria. MPST mediates the transfer of a sulfur atom from 3-methylpryuvate (3MPYR) to HCN to form the less toxic thiocyanic acid (HSCN) (Himwich & Saunders 1948, Zottola 2009, Moeller et al. 2017). HSCN can be excreted in urine via the kidneys (Hamel 2011). Although the primary role of MPST is not cyanide detoxification, a large body of animal data has demonstrated cyanide is rapidly converted to thiocyanate in vivo when 3MPYR is administered, even in species with low MPST activity (Brenner et al. 2010, Belani et al. 2012).
R-HSA-9013533 (Reactome) Cyanide is a potent metabolic poison which binds to and inhibits cytochrome c oxidase (cytochrome a3), resulting in the rapid inhibition of oxidative phosphorylation (Hall & Rumack 1986). As a result, cells can't utilise oxygen, giving rise to central nervous system, cardiovascular and respiratory dysfunction that can result in permanent neurological defects and, in severe cases, death. At body's pH, cyanide exists mainly in the undissociated form hydrogen cyanide (HCN) which can cross cellular and subcellular membranes such as the blood brain barrier and mitochondrial membranes. Although humans are not typically exposed to cyanide, cyanide intoxication can occur after smoke inhalation, industrial exposure, ingestion of cyanogenic substances and cyanogenic food sources such as cassava. Antidotes for HCN poisoning cases include HCN binders, sulfur donors that convert HCN to the less toxic thiosulfate and competitors for HCN enzymatic binding sites such as NO (Petrikovics et al. 2015).

Two pathways in mammals are able to detoxify cyanide as thiocyanate via transfer of a sulfur atom: thiosulfate sulfurtransferase (TST aka rhodanese) in mitochondria and 3-mercaptopyruvate sulfurtransferase (MPST aka 3MST) in cytosol and mitochondria. 3MPYR has been investigated for the potential treatment of HCN poisoning but its half life is very short, being rapidly metabolised when given intravenously (Nagahara & Sawada 2003). Also, it is a metabolite of cysteine metabolism but cysteine is present in low amounts in the brain and heart, limiting the ability of MPST to be effective in acute HCN poisoning. The pro-drug sulfanegen is the hemithioacetal cyclic dimer of 3MPYR and has been demonstrated to be effective against HCN poisoning in animal studies (Brenner et al. 2010, Belani et al. 2012). Sulfanegen provides the sulfur atom for the transsulfuration of HCN by MPST (Belani et al. 2012). HSCN can be excreted in urine via the kidneys (Hamel 2011). In a mass exposure scenario (such as terrorism or industrial accident), a rapidly-acting antidote that can be administered quickly to a large number of people is essential; sulfanegen can be rapidly administered by intramuscular injection (Patterson et al. 2016).
R-HSA-9034756 (Reactome) Hydrogen polysulfides (H2Sn, where n>=2) are also endogenously produced by 3-mercaptopyruvate sulfurtransferase (MPST aka 3MST) directly from 3-mercaptopyruvate (3MPYR) generated by cysteine (aspartate) aminotransferase (GOT2) (Kimura et al. 2013, Kimura et al. 2015, Koike et al. 2017). Where n=2, the H2S2 species is called hydrogen persulfide (aka disulfane). MPST can release either H2S or H2Sn depending on the interaction with thioredoxin. When there is strong interaction with thioredoxin, H2S is released. 3MST receives sulfur from 3MPYR to persulfurate (oxidise) cysteine-248 residue of its reaction centre.

H2S2 is the dominant form produced with H2S3 detected at lower concentrations in cells or tissues. Up to H2S35 may exist (Steudel 2003), but under physiological conditions, when n reaches 8, it forms a crown shape and precipitates. H2Sn activate transient receptor potential ankyrin 1 (TRPA1) channels (Kimura et al. 2013), facilitate translocation of nuclear factor like-2 (NRF2) to the nucleus by modifying its binding partner kelch-like ECH-associated protein 1 (KEAP1) (Koike et al. 2013), regulates the activity of the tumor suppressor phosphatase and tensin homolog (PTEN) (Greiner et al. 2013), and reduces blood pressure by activating protein kinase G1a (Stubbert et al. 2014). Another persulfurated molecule, cysteine persulfide, which may be involved in the regulation of cellular redox homeostasis, is also produced by MPST (Kimura et al. 2017).
R-HSA-9035227 (Reactome) A polysulfur chain may be produced at the catalytic site of CysS248-MPST. H2Sn is released after CysS248-MPST binds mitochondrial thioredoxin (TXN2) (Smeets et al. 2005, Yadav et al. 2013, Holzerova et al. 2016). The length of the sulfur chain released from MPST may vary depending on the availability of thioredoxin (Kimura 2016). When the interaction between MPST and thioredoxin is strong, the shorter form H2S can be released.
R-HSA-9035484 (Reactome) A polysulfur chain may be produced at the catalytic site of CysS248-MPST. H2Sn is released after CysS248-MPST binds mitochondrial thioredoxin (TXN2) (Smeets et al. 2005, Yadav et al. 2013, Holzerova et al. 2016). The length of the sulfur chain released from MPST may vary depending on the availability of thioredoxin (Kimura 2016). When the interaction between MPST and thioredoxin is strong, the shorter form H2S can be released. Thioredoxin is now in the oxidised, disulfide form (HC-TXN2) and can be reduced by thioredoxin reductase in the presence of NADPH (Smeets et al. 2005, Yadav et al. 2013).
S2O3(2-)ArrowR-HSA-1614618 (Reactome)
S2O3(2-)ArrowR-HSA-9012721 (Reactome)
S2O3(2-)R-HSA-1655879 (Reactome)
S2O3(2-)R-HSA-9013198 (Reactome)
SLC25A10mim-catalysisR-HSA-1614546 (Reactome)
SMMR-HSA-5696838 (Reactome)
SO3(2-)ArrowR-HSA-9013198 (Reactome)
SO4(2-)ArrowR-HSA-1614544 (Reactome)
SO4(2-)ArrowR-HSA-1614546 (Reactome)
SO4(2-)R-HSA-1614546 (Reactome)
SQR:FADmim-catalysisR-HSA-1614665 (Reactome)
SQRDL(1-450)ArrowR-HSA-1614605 (Reactome)
SQRDL(1-450)ArrowR-HSA-1614618 (Reactome)
TAUArrowR-HSA-1655453 (Reactome)
TSTD1mim-catalysisR-HSA-1655879 (Reactome)
TSTmim-catalysisR-HSA-1614618 (Reactome)
TSTmim-catalysisR-HSA-9013198 (Reactome)
TXN2R-HSA-9035227 (Reactome)
holo-SUOXmim-catalysisR-HSA-1614544 (Reactome)
sulfanegenR-HSA-9013533 (Reactome)
sulfite(2-)ArrowR-HSA-1614605 (Reactome)
sulfite(2-)ArrowR-HSA-1655879 (Reactome)
sulfite(2-)R-HSA-1614544 (Reactome)
sulfite(2-)R-HSA-1614618 (Reactome)
Personal tools